Reducing the risk of long COVID
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Prevention works at four points: avoiding infection, being vaccinated when infection happens, what is done in the first days of illness, and how the weeks afterwards are handled.
None of it is a guarantee. The honest version is that these shift the odds, and that people who do everything right still get long COVID.
Related pages: Long COVID · COVID-19
The bottom line
- Avoiding infection is the only certain prevention.
- Vaccination reduces long COVID risk.
- Each reinfection carries additional risk.
- No intervention eliminates the risk.
- How much antivirals during acute infection reduce long COVID, where evidence is mixed.
- Whether metformin findings will replicate in other groups.
The story, step by step
- 1. Vaccination ()
- 2. Avoiding infection ()
- 3. The first five days ()
- 4. The weeks afterwards ()
- 5. Honest limits ()
What the evidence labels mean
The clearest single measure
What happens
What vaccination does for long COVID risk specifically.
What the research shows
- Being up to date with COVID vaccination is associated with a lower risk of long COVID after an infection, with estimates commonly in the range of 30 to 50 percent lower.
- Estimates vary widely between studies, from modest to substantial, and most are observational rather than randomized, so the true effect is uncertain.
- Vaccination also reduces severe acute illness, and severe acute illness is itself a risk factor for long COVID, so part of the benefit runs through that.
- It does not eliminate the risk. People who are fully vaccinated do develop long COVID.
- Vaccination after developing long COVID: most studies find symptoms unchanged or slightly improved on average, with some people reporting worsening. It is a reasonable conversation to have rather than a clear answer.
Why it matters
This is the measure with the most support, and it is partial rather than protective. Both halves of that matter.
What's still uncertain
- Most evidence is observational and estimates vary considerably.
Read more
- CDC: Long COVIDGovernment
- OwieClear: Long COVID: what the research has found so farOwieClear
Next: Avoiding infection
Air and masks
What happens
The measures that reduce the chance of infection in the first place.
What the research shows
- SARS-CoV-2 spreads mainly through aerosols that accumulate in poorly ventilated indoor spaces.
- Ventilation dilutes them: opening windows, cross-ventilation, upgrading building filters, and portable HEPA air cleaners in shared rooms.
- A well-fitting N95, KN95 or FFP2 respirator filters most airborne particles. Fit matters more than the label: gaps at the sides defeat the filter.
- Timing precautions to local transmission levels, using wastewater data where available, is more sustainable than permanent precautions for most people.
- Each infection carries its own risk, and observational studies suggest reinfections add further risk rather than being harmless.
- This is one of the few areas where people with long COVID have a specific reason for ongoing caution, since reinfection can set recovery back.
Why it matters
Air quality is the under-used half of this. A HEPA cleaner in a shared room does continuous work that a mask only does while worn.
What's still uncertain
- How much individual precautions reduce risk in everyday settings is hard to quantify.
Read more
- CDC: Long COVIDGovernment
- MedlinePlus: COVID-19Government
Next: The first five days
Acute treatment
What happens
What can be done during the acute infection.
What the research shows
- Antivirals, nirmatrelvir with ritonavir or remdesivir, reduce severe acute illness in people at higher risk and are given early in the infection.
- Whether they reduce long COVID is less settled. Large observational studies have suggested a benefit, and more rigorous analyses have been mixed. It should be described as possible rather than established.
- Nirmatrelvir has significant interactions with many common medications, including some statins, blood thinners and heart rhythm drugs. A full medication review is part of prescribing it, and that is not optional.
- Metformin: in a randomized trial in adults with overweight or obesity, a 14-day course started within a few days of symptom onset reduced long COVID incidence by roughly 40 percent. That is one trial in one population, it is not standard practice, and it is a conversation to have with a prescribing clinician during an acute infection rather than afterwards.
- Saline nasal rinses may ease acute symptoms. Use distilled, or boiled and cooled, water, never untreated tap water, because of a rare but fatal brain infection. There is no evidence they prevent long COVID.
- Nothing here is a reason to delay seeking care if an acute infection is getting worse.
Why it matters
If you are eligible for antivirals, the window is short, so knowing in advance whether you qualify is worth doing before you are ill.
What's still uncertain
- Evidence that antivirals prevent long COVID remains mixed.
Read more
- CDC: Long COVIDGovernment
- MedlinePlus: COVID-19Government
Next: The weeks afterwards
Convalescence
What happens
What happens after the acute illness appears to matter.
What the research shows
- Returning to intense exercise too quickly after COVID is associated with worse outcomes, and is a common pattern in people who were fit beforehand.
- Rest during the acute illness, then a gradual return over several weeks after symptoms resolve, is the usual advice.
- If unusual fatigue, a racing heart on standing, or breathlessness persists beyond about four weeks, that is the point to switch from pushing through to pacing.
- This is the moment where the advice diverges from ordinary recovery advice, and getting it wrong appears to matter.
- Chest pain, severe breathlessness, fainting, or a swollen painful calf after COVID need assessment rather than rest, because clots and heart inflammation both occur.
- Baseline health matters too: blood pressure, blood sugar, weight, smoking and untreated sleep apnoea are all associated with worse outcomes, and all are modifiable before any infection.
Why it matters
The four-week mark is the practical signal. Symptoms still present then are a reason to change approach rather than to try harder.
What's still uncertain
- The optimal return-to-activity approach after COVID is not established.
Read more
- CDC: Long COVIDGovernment
- OwieClear: Pacing and the energy envelopeOwieClear
Next: Honest limits
What this does not do
What happens
The part worth saying plainly.
What the research shows
- None of this eliminates the risk. People who are vaccinated, masked, treated early and careful in convalescence still develop long COVID.
- Risk per infection appears lower than early in the pandemic, with vaccination and changed variants, and it is not zero.
- Nothing sold as a long COVID prevention supplement has evidence behind it.
- Long COVID is not caused by anything a person did or failed to do, and framing prevention as personal responsibility leaves people who have it carrying blame they do not deserve.
- Children and young people get long COVID too, including after mild infections.
- The measures above are worth taking because they shift the odds, which is the most that can honestly be claimed.
Why it matters
Worth doing, and not a guarantee. Anyone with long COVID who followed all of this did not do anything wrong.
What's still uncertain
- Absolute risk estimates vary widely by study, variant and population.
Read more
- CDC: Long COVIDGovernment
- NIH RECOVER: Researching COVID to enhance recoveryGovernment